Mullin, Booker Introduce Bipartisan Prescription Information Modernization Act

WASHINGTON, D.C. — Today, U.S. Senators Markwayne Mullin (R-OK) and Cory Booker (D-NJ) introduced the bipartisan Prescription Information Modernization Act, legislation that would enable the Food and Drug Administration (FDA) to implement a rule that allows drug manufacturers to transmit prescribing information electronically in order to reduce waste, improve efficiency, and ensure that healthcare professionals have access to the latest drug information.

Prescribing information is crucial for healthcare professionals to make informed decisions about drug prescriptions. However, under current regulations, this information is required to be printed which leads to excessive paper use and the distribution of outdated materials.

“Current prescription information distribution is outdated for the digital age,” said Senator Mullin. “Electronic prescriptions will simplify how providers access and manage prescription data, improving efficiency without compromising patient care quality. I am confident this change will help medical professionals provide the most up-to-date, accurate care to their patients.”

“Our health care system has been slow to adopt the latest technology that can help make our health care more efficient,” said Senator Booker. “By ensuring our healthcare system embraces digital innovation, we can help reduce waste and prioritize access to accurate information. I am proud to introduce this bipartisan legislation that will modernize our health care practices and help improve patient outcomes.”

The legislation is supported by the following organizations: The Alliance to Modernize Prescribing Information, Academy of Managed Care Pharmacy (AMCP), Allergy & Asthma Network, American Pharmacists Association, AmGen, Asthma and Allergy Foundation of America, Association for Accessible Medicines, Beyond Type 1, Biotechnology Innovation Organization, BioNJ, BioUtah, Boomer Esiason Foundation, Environmental Paper Network, Georgia Bio, Healthcare Distribution Alliance, HealthCare Institute of New Jersey, LUNGevity Foundation, Lupin, Maryland Tech Council, MassBio, McKesson, National Association of Chain Drug Stores, National Consumers League, National Grange, NewYorkBIO, North Carolina Biosciences Organization, Texas Healthcare and Biosciences Institute, and Zero Cancer.

The full text of the bill can be found here